Business
Press Release Jan 25 2024
Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 25, 2024, titled "Strides receives USFDA approval for Pregabalin Capsules".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated January 25, 2024, titled "Strides receives USFDA approval for Pregabalin Capsules". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd